OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Carvedilol attenuates brain damage in mice with hepatic encephalopathy
Keyvan Amirshahrokhi, Ali Niapour
International Immunopharmacology (2022) Vol. 111, pp. 109119-109119
Closed Access | Times Cited: 13
Keyvan Amirshahrokhi, Ali Niapour
International Immunopharmacology (2022) Vol. 111, pp. 109119-109119
Closed Access | Times Cited: 13
Showing 13 citing articles:
Cellular Pathogenesis of Hepatic Encephalopathy: An Update
Kaihui Lu
Biomolecules (2023) Vol. 13, Iss. 2, pp. 396-396
Open Access | Times Cited: 28
Kaihui Lu
Biomolecules (2023) Vol. 13, Iss. 2, pp. 396-396
Open Access | Times Cited: 28
Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis
Sarah‐Louise Gillespie, Timothy P. Hanrahan, Don C. Rockey, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 5, pp. 454-463
Open Access | Times Cited: 14
Sarah‐Louise Gillespie, Timothy P. Hanrahan, Don C. Rockey, et al.
Alimentary Pharmacology & Therapeutics (2023) Vol. 57, Iss. 5, pp. 454-463
Open Access | Times Cited: 14
Levetiracetam attenuates experimental ulcerative colitis through promoting Nrf2/HO-1 antioxidant and inhibiting NF-κB, proinflammatory cytokines and iNOS/NO pathways
Keyvan Amirshahrokhi, Mahsa Imani
International Immunopharmacology (2023) Vol. 119, pp. 110165-110165
Closed Access | Times Cited: 14
Keyvan Amirshahrokhi, Mahsa Imani
International Immunopharmacology (2023) Vol. 119, pp. 110165-110165
Closed Access | Times Cited: 14
Dahuang-Wumei decoction protects against hepatic encephalopathy in mice: Behavioural, biochemical, and molecular evidence
Qiong Liu, Xin Ba, Liang Han, et al.
Phytomedicine (2024) Vol. 128, pp. 155419-155419
Closed Access | Times Cited: 4
Qiong Liu, Xin Ba, Liang Han, et al.
Phytomedicine (2024) Vol. 128, pp. 155419-155419
Closed Access | Times Cited: 4
Edaravone reduces brain injury in hepatic encephalopathy by upregulation of Nrf2/HO-1 and inhibition of NF-κB, iNOS/NO and inflammatory cytokines
Keyvan Amirshahrokhi, Mahsa Imani
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Keyvan Amirshahrokhi, Mahsa Imani
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Inhibition of protein glycation by vasodilatory β-blockers – In vitro studies and in silico analyses
Szymon Drygała, Małgorzata Żendzian‐Piotrowska, Michał Radzikowski, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117976-117976
Closed Access
Szymon Drygała, Małgorzata Żendzian‐Piotrowska, Michał Radzikowski, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117976-117976
Closed Access
Carvedilol attenuates inflammatory reactions of lipopolysaccharide-stimulated BV2 cells and modulates M1/M2 polarization of microglia via regulating NLRP3, Notch, and PPAR-γ signaling pathways
Mohammadjavad Khoshnavay Foumani, Keyvan Amirshahrokhi, Zeinab Namjoo, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 7, pp. 4727-4736
Closed Access | Times Cited: 7
Mohammadjavad Khoshnavay Foumani, Keyvan Amirshahrokhi, Zeinab Namjoo, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 7, pp. 4727-4736
Closed Access | Times Cited: 7
The Mechanism of Hepatic Encephalopathy Induced by Thioacetamide Based on Metabolomics and Proteomics: A Preliminary Study
Honghui Guo, Guang Wang, Huang Wei, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 284-284
Open Access | Times Cited: 5
Honghui Guo, Guang Wang, Huang Wei, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 284-284
Open Access | Times Cited: 5
Therapeutic Effect of Levetiracetam Against Thioacetamide-Induced Hepatic Encephalopathy Through Inhibition of Oxidative Stress and Downregulation of NF-κB, NLRP3, iNOS/NO, Pro-Inflammatory Cytokines and Apoptosis
Keyvan Amirshahrokhi, Mahsa Imani
Inflammation (2024)
Closed Access | Times Cited: 1
Keyvan Amirshahrokhi, Mahsa Imani
Inflammation (2024)
Closed Access | Times Cited: 1
β-blockers and metabolic modulation: unraveling the complex interplay with glucose metabolism, inflammation and oxidative stress
Szymon Drygała, Michał Radzikowski, Mateusz Maciejczyk
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Szymon Drygała, Michał Radzikowski, Mateusz Maciejczyk
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Prognostic value of virtual portal pressure gradient response in compensated cirrhotic patients treated with carvedilol
Shuo Zhang, Li Cai, Hui Zhong, et al.
Hepatology Research (2023) Vol. 54, Iss. 1, pp. 78-90
Open Access | Times Cited: 2
Shuo Zhang, Li Cai, Hui Zhong, et al.
Hepatology Research (2023) Vol. 54, Iss. 1, pp. 78-90
Open Access | Times Cited: 2
M2-type macrophage membrane-mediated delivery of Carvedilol nanocomplex for acute liver failure treatment and remodeling inflammatory microenvironment
Mingge Shang, Yaohui Zhang, Junjie Qian, et al.
Nano Research (2024) Vol. 17, Iss. 7, pp. 6362-6375
Closed Access
Mingge Shang, Yaohui Zhang, Junjie Qian, et al.
Nano Research (2024) Vol. 17, Iss. 7, pp. 6362-6375
Closed Access
The Impact of Heart Failure Chronic Treatment Prior to Cardiac Transplantation on Early Outcomes
Dragoş-Florin Babă, Horațiu Suciu, Călin Avram, et al.
Medicina (2024) Vol. 60, Iss. 11, pp. 1801-1801
Open Access
Dragoş-Florin Babă, Horațiu Suciu, Călin Avram, et al.
Medicina (2024) Vol. 60, Iss. 11, pp. 1801-1801
Open Access
